KRYS logo

Krystal Biotech (KRYS) Shareholders Equity

Annual Shareholders Equity

$778.64 M
+$256.41 M+49.10%

December 31, 2023


Summary


Performance

KRYS Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKRYSbalance sheetmetrics:

Quarterly Shareholders Equity

$885.85 M
+$46.95 M+5.60%

September 30, 2024


Summary


Performance

KRYS Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKRYSbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

KRYS Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+49.1%+17.2%
3 y3 years+166.6%+69.6%
5 y5 years+587.7%+69.6%

KRYS Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+49.1%at high+81.0%
5 y5-yearat high+283.7%at high+346.6%
alltimeall timeat high>+9999.0%at high>+9999.0%

Krystal Biotech Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$885.85 M(+5.6%)
Jun 2024
-
$838.89 M(+5.0%)
Mar 2024
-
$799.24 M(+2.6%)
Dec 2023
$778.64 M(+49.1%)
$778.64 M(+3.0%)
Sep 2023
-
$755.95 M(+15.7%)
Jun 2023
-
$653.11 M(+33.4%)
Mar 2023
-
$489.57 M(-6.3%)
Dec 2022
$522.23 M(-12.0%)
$522.23 M(-3.4%)
Sep 2022
-
$540.77 M(-3.3%)
Jun 2022
-
$559.18 M(+1.9%)
Mar 2022
-
$548.55 M(-7.6%)
Dec 2021
$593.58 M(+103.2%)
$593.58 M(+45.4%)
Sep 2021
-
$408.24 M(-2.5%)
Jun 2021
-
$418.54 M(-2.8%)
Mar 2021
-
$430.65 M(+47.4%)
DateAnnualQuarterly
Dec 2020
$292.08 M(+43.9%)
$292.08 M(-3.2%)
Sep 2020
-
$301.72 M(-2.6%)
Jun 2020
-
$309.70 M(+56.1%)
Mar 2020
-
$198.37 M(-2.2%)
Dec 2019
$202.91 M(+79.2%)
$202.91 M(-2.3%)
Sep 2019
-
$207.65 M(+4.7%)
Jun 2019
-
$198.29 M(+81.1%)
Mar 2019
-
$109.49 M(-3.3%)
Dec 2018
$113.23 M(+128.9%)
$113.23 M(+116.5%)
Sep 2018
-
$52.29 M(+15.5%)
Jun 2018
-
$45.27 M(-4.5%)
Mar 2018
-
$47.40 M(-4.2%)
Dec 2017
$49.47 M(>+9900.0%)
$49.47 M(-1.4%)
Sep 2017
-
$50.20 M(+1379.5%)
Jun 2017
-
$3.39 M(+1074.0%)
Dec 2016
$289.00 K
$289.00 K

FAQ

  • What is Krystal Biotech annual stockholders equity?
  • What is the all time high annual shareholders equity for Krystal Biotech?
  • What is Krystal Biotech annual shareholders equity year-on-year change?
  • What is Krystal Biotech quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Krystal Biotech?
  • What is Krystal Biotech quarterly shareholders equity year-on-year change?

What is Krystal Biotech annual stockholders equity?

The current annual shareholders equity of KRYS is $778.64 M

What is the all time high annual shareholders equity for Krystal Biotech?

Krystal Biotech all-time high annual stockholders equity is $778.64 M

What is Krystal Biotech annual shareholders equity year-on-year change?

Over the past year, KRYS annual stockholders equity has changed by +$256.41 M (+49.10%)

What is Krystal Biotech quarterly stockholders equity?

The current quarterly shareholders equity of KRYS is $885.85 M

What is the all time high quarterly shareholders equity for Krystal Biotech?

Krystal Biotech all-time high quarterly stockholders equity is $885.85 M

What is Krystal Biotech quarterly shareholders equity year-on-year change?

Over the past year, KRYS quarterly stockholders equity has changed by +$129.90 M (+17.18%)